Correlation Between Apellis Pharmaceuticals and Achieve Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and Achieve Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and Achieve Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apellis Pharmaceuticals and Achieve Life Sciences, you can compare the effects of market volatilities on Apellis Pharmaceuticals and Achieve Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of Achieve Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and Achieve Life.

Diversification Opportunities for Apellis Pharmaceuticals and Achieve Life

-0.1
  Correlation Coefficient

Good diversification

The 3 months correlation between Apellis and Achieve is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and Achieve Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Achieve Life Sciences and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with Achieve Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Achieve Life Sciences has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and Achieve Life go up and down completely randomly.

Pair Corralation between Apellis Pharmaceuticals and Achieve Life

Given the investment horizon of 90 days Apellis Pharmaceuticals is expected to generate 1.1 times more return on investment than Achieve Life. However, Apellis Pharmaceuticals is 1.1 times more volatile than Achieve Life Sciences. It trades about -0.1 of its potential returns per unit of risk. Achieve Life Sciences is currently generating about -0.12 per unit of risk. If you would invest  3,316  in Apellis Pharmaceuticals on November 3, 2024 and sell it today you would lose (366.00) from holding Apellis Pharmaceuticals or give up 11.04% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Apellis Pharmaceuticals  vs.  Achieve Life Sciences

 Performance 
       Timeline  
Apellis Pharmaceuticals 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Apellis Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak essential indicators, Apellis Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in March 2025.
Achieve Life Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Achieve Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical indicators remain fairly stable which may send shares a bit higher in March 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Apellis Pharmaceuticals and Achieve Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Apellis Pharmaceuticals and Achieve Life

The main advantage of trading using opposite Apellis Pharmaceuticals and Achieve Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, Achieve Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Achieve Life will offset losses from the drop in Achieve Life's long position.
The idea behind Apellis Pharmaceuticals and Achieve Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities